title: Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization.
abstract: Management of extraocular diseases is mainly limited by the inability to provide long-term drug delivery without avoiding the systemic drug exposure and/or affecting the intraocular structures and poor availability of drugs, which may be overcome by prolonging the contact time with the ocular system, for instance with liposomes. Development and optimization of reverse phase evaporation ciprofloxacin (CPF) HCl liposomes for ocular drug delivery was carried out using a 2(5) full factorial design based on five independent variables. The effects of the studied parameters on drug entrapment efficiency (EE), particle size, and percentage of drug released after 1 and 10 h were investigated. The results obtained pointed out that the molar concentration of cholesterol was the predominant factor that increased the EE% of the drug and the particle size responses. The percentage of drug released after 1 h was significantly controlled by the initial CPF concentration while that after 10 h was controlled by molar cholesterol concentration. The designed liposomes had average particle sizes that ranged from 2.5 to 7.23 microm. In addition, liposomes revealed a fast release during the first hour followed by a more gradual drug release during the 24-h period according to Higuchi diffusion model.
authors.affiliation: Industrial Pharmacy Department, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. dr_mehanna@yahoo.com
authors.forename: Mohammed M
authors.initials: MM
authors.lastname: Mehanna
authors.forename: Hoda A
authors.initials: HA
authors.lastname: Elmaradny
authors.forename: Magda W
authors.initials: MW
authors.lastname: Samaha
mesh_terms: D000465:Algorithms; D000704:Analysis of Variance; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D002784:Cholesterol / Q000737:chemistry; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000737:chemistry; D004337:Drug Carriers; D016503:Drug Delivery Systems; D015195:Drug Design; D004705:Endocytosis; D005079:Excipients; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008081:Liposomes / Q000737:chemistry*; D015233:Models, Statistical; D009883:Ophthalmic Solutions / Q000737:chemistry*; D010755:Organophosphates / Q000737:chemistry; D010316:Particle Size
chemical_list: D000900:Anti-Bacterial Agents; D004337:Drug Carriers; D005079:Excipients; D008081:Liposomes; D009883:Ophthalmic Solutions; D010755:Organophosphates; C002290:dicetylphosphate; D002939:Ciprofloxacin; D002784:Cholesterol